HCPLive Network

Lawrence Brandt, MD, on Fecal Microbiota Transplant Study, Part I

Lawrence Brandt, MD, professor of medicine and surgery at the Albert Einstein College of Medicine in New York City, discusses a study on the outcomes of fecal microbiota transplants on almost 100 patients across the country with refractory Clostridium difficile colitis. He explains that 91 percent of the patients experienced prompt relief. Including those who underwent a second transplant or a post-transplant course of medication, 98.3 percent of the patients experienced relief. This video was shot at the annual scientific conference of the American College of Gastroenterology.

Related Videos
Patricia Finn, MD, president of the American Thoracic Society, highlights 3 presentations at the 2014 American Thoracic Society International Conference that link science and health equality.
Although diagnosing pneumonia is the same regardless of whether the patient is immunocompetent or immunocompromised, the physician needs to understand the patient’s host defense.
Although researchers discovered a plasma biomarker that can predict the development of acute respiratory distress syndrome in emergency room patients, the condition is usually already present.